Angiopoietin-2 as a biomarker for metabolic syndrome and disease activity in rheumatoid arthritis patients

Stavropoulos-Kalinoglou, 2009, Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis, Ann Rheum Dis, 68, 242, 10.1136/ard.2008.095596 Kassem, 2011, Non traditional risk factors of carotid atherosclerosis in rheumatoid arthritis, Egypt Rheumatol, 33, 113, 10.1016/j.ejr.2011.03.005 Abaza, 2013, Deficient or abundant but unable to fight? Estimation of circulating FoxP3+ T regulatory cells and their counteracting FoxP3− in rheumatoid arthritis and correlation with disease activity, Egypt Rheumatol, 35, 185, 10.1016/j.ejr.2013.03.005 Gaber, 2013, Clinical significance of serum interleukin-6 and −174 G/C promoter polymorphism in rheumatoid arthritis patients, Egypt Rheumatol, 35, 107, 10.1016/j.ejr.2012.11.002 Gheita, 2015, Clinical significance of serum TNF-α and −308 G/A promoter polymorphism in rheumatoid arthritis, Egypt Rheumatol, 37, 49, 10.1016/j.ejr.2014.07.001 El-barbary, 2011, Assessment of lipid peroxidation and antioxidant status in rheumatoid arthritis and osteoarthritis patients, Egypt Rheumatol, 33, 179, 10.1016/j.ejr.2011.07.002 Hassan, 2011, Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity, Int J Rheum Dis, 14, 325, 10.1111/j.1756-185X.2011.01630.x Gheita, 2012, Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study, Phytother Res, 26, 1246, 10.1002/ptr.3679 Ghorbanihaghjo, 2014, Osteoprotegerin (OPG) and Matrix Gla protein (MGP) in rheumatoid arthritis patients: relation to disease activity, 36, 111 Abdalla, 2014, Serum leptin levels in rheumatoid arthritis and relationship with disease activity, Egypt Rheumatol, 36, 1, 10.1016/j.ejr.2013.10.002 Helal, 2012, Fatigue in rheumatoid arthritis and its relation to interleukin-6 serum level, Egypt Rheumatol, 34, 153, 10.1016/j.ejr.2012.08.004 Ahmed, 2013, Assessment of synovitis in early rheumatoid arthritis by CXCL13 serum levels and power Doppler ultrasonography: correlation with disease activity, Egypt Rheumatol, 35, 21, 10.1016/j.ejr.2012.09.001 Al-Zifzaf, 2015, FoxP3+T regulatory cells in rheumatoid arthritis and the imbalance of the Treg/TH17 cytokine axis, Egypt Rheumatol, 37, 7, 10.1016/j.ejr.2014.06.004 Gheita, 2014, Subclinical reduced G6PD activity in rheumatoid arthritis and Sjögren’s syndrome patients: relation to clinical characteristics, disease activity and metabolic syndrome, Mod Rheumatol, 24, 612, 10.3109/14397595.2013.851639 Costa, 2007, Angiogenesis and chronic inflammation: cause or consequence?, Angiogenesis, 10, 149, 10.1007/s10456-007-9074-0 Haffner, 1992, Prospective analysis of the insulin-resistance syndrome (syndrome X), Diabetes, 41, 715, 10.2337/diab.41.6.715 Grundy, 2004, Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition, Circulation, 109, 433, 10.1161/01.CIR.0000111245.75752.C6 Lakka, 2002, The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men, JAMA, 288, 2709, 10.1001/jama.288.21.2709 Gheita, 2012, Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions, Int J Rheum Dis, 15, 521, 10.1111/1756-185X.12007 Gheita, 2013, Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness, Z Rheumatol, 72, 172, 10.1007/s00393-012-1058-9 Baraka, 2015, Hyperhomocysteinemia and metabolic syndrome are risk factors for sub-clinical atherosclerosis in women with systemic lupus erythematosus, Egypt Rheumatol, 37, 67, 10.1016/j.ejr.2014.07.006 El Sayed, 2014, Insulin resistance as a risk factor for subclinical atherosclerosis in rheumatoid arthritis, Egypt Rheumatol, 36, 7, 10.1016/j.ejr.2013.08.003 Alsalawy, 2012, Correlation between serum osteoprotegerin and atherosclerotic vascular disorders in rheumatoid arthritis patients, Egypt Rheumatol, 34, 35, 10.1016/j.ejr.2011.10.002 Thurston, 2003, Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis, Cell Tissue Res, 314, 61, 10.1007/s00441-003-0749-6 Roviezzo, 2005, Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage, J Pharmacol Exp Ther, 314, 738, 10.1124/jpet.105.086553 Aletaha, 2010, 2010 Rheumatoid Arthritis Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, 62, 2569, 10.1002/art.27584 National Cholesterol Education Program Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001, Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Prevoo, 1995, Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis Rheum, 38, 44, 10.1002/art.1780380107 Majithia, 2007, Rheumatoid arthritis: diagnosis and management, Am J Med, 120, 936, 10.1016/j.amjmed.2007.04.005 Maradit-Kremers, 2005, Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study, Arthritis Rheum, 52, 402, 10.1002/art.20853 Libby, 2008, Role of inflammation in atherosclerosis associated with rheumatoid arthritis, Am J Med, 121, S21, 10.1016/j.amjmed.2008.06.014 Gale, 2002, Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1, Dev Cell, 3, 411, 10.1016/S1534-5807(02)00217-4 Lieb, 2010, Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community, Circ Cardiovasc Genet, 3, 300, 10.1161/CIRCGENETICS.109.914556 Westra, 2011, Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular disease, Rheumatology (Oxford), 50, 665, 10.1093/rheumatology/keq378 Soliman, 2014, Significance of serum levels of angiopoietin-2 and its relationship to Doppler ultrasonographic findings in rheumatoid arthritis patients, Egypt Rheumatol, 36, 15, 10.1016/j.ejr.2013.09.001 Lim, 2004, Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention, Diabetes Care, 27, 2918, 10.2337/diacare.27.12.2918 Patel, 2008, Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension, Ann Med, 40, 215, 10.1080/07853890701779586 Anuradha, 2010, Angiopoietin-2 levels in glucose intolerance, hypertension, and metabolic syndrome in Asian Indians (Chennai Urban Rural Epidemiology Study-74), Metabolism, 59, 774, 10.1016/j.metabol.2009.09.022 Kennedy, 2010, Angiogenesis and blood vessel stability in inflammatory arthritis, Arthritis Rheum, 62, 711, 10.1002/art.27287